Search
for
Sort by
Research 31–60 of 131
- Clinical characterization of men with long QT syndrome and torsades de pointes associated with hypogonadism: A review and pharmacovigilance study
- Targeting host cell proteases as a potential treatment strategy to limit the spread of SARS‐CoV‐2 in the respiratory tract
- Targets to treat androgen excess in polycystic ovary syndrome
- Androgen deprivation therapy may constitute a more effective COVID-19 prophylactic than therapeutic strategy
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- Repurposing steroidogenesis inhibitors for the therapy of neuropsychiatric disorders: Promises and caveats
- Abiraterone and spironolactone in prostate cancer: a combination to avoid
- COVID‐19, androgens, and androgenic alopecia
- Proxalutamide Reduction of Mortality Rate in Hospitalized COVID-19 Patients Depends on Treatment Duration – an Exploratory Analysis of the Proxa-Rescue AndroCoV Trial
- TMPRSS2: A Key Host Factor in SARS-CoV-2 Infection and Potential Therapeutic Target
- Imaging prostate cancer (PCa) with [<sup>99m</sup> Tc(CO)<sub>3</sub> ]finasteride dithiocarbamate
- 5α-Reductase Inhibitors Do Not Prevent the Development and Progression of Urothelial Cancer: In Vitro Evidence
- Steroid Hormones
- Angelica gigas Nakai (Korean Dang-gui) Root Alcoholic Extracts in Health Promotion and Disease Therapy – active Phytochemicals and In Vivo Molecular Targets
- Retardation of Preputial Wound Healing in Rats with Hypospadias Induced by Flutamide
- Androgen Receptor Ligands: Agonists and Antagonists
- Association of long-term 5α-reductase inhibitor use with survival in men with renal cell carcinoma: a nationwide population-based cohort study
- Sexual dimorphism of COVID-19 inspires drug repositioning and host-targeting immunotherapy for viral pneumonia
- Bioavailability File: Bicalutamide
- Optimized Nanostructured Lipid Carriers for Dutasteride Delivery: Improving Therapeutic Efficiency and Minimizing Adverse Effects
- Topical solutions for androgenetic alopecia: evaluating efficacy and safety
- Hétérogénéité tumorale du cancer de la prostate et infection par le SARS-CoV2 : une relation complexe impliquant les vésicules extracellulaires et le récepteur des androgènes
- Androgen deprivation therapy and hormonal status in men with COVID-19
- Reply to comment on: The Gabrin sign
- Periungual lesions secondary to chemotherapy with docetaxel
- Steroid Hormones of Reproduction and Sexual Development
- Steroidogenesis in steroid related cancers
- Sex hormones and related compounds, including hormonal contraceptives
- A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma – the DUCT study protocol
- Index